Consumer products giant Clorox (NYSE: CLX) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 18.9% year on year to $1.43 billion. Its non-GAAP profit of $0.85 per share was 9.2% above analysts’ consensus estimates.

Is now the time to buy CLX? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Clorox’s third quarter results were received positively by the market, as the company beat Wall Street’s revenue and non-GAAP profit expectations despite a sharp year-over-year sales decline. Management attributed the performance to operational progress following the U.S. launch of a new enterprise resource planning (ERP) system, which strengthened Clorox’s digital infrastructure but contributed to short-term disruptions. CEO Linda Rendle emphasized that, while the ERP transition presented challenges, its successful implementation has already begun delivering operational benefits and will support future efficiency gains.

For the remainder of the year, Clorox’s outlook is anchored by an expectation of gradual category stabilization and renewed innovation across its major brands. Management highlighted that the company’s demand creation plan, supported by increased advertising and targeted promotional activities, is designed to regain market share and drive a return to organic sales growth in the back half. CFO Luc Bellet noted, “We feel good about our ability to meet our gross margin outlook,” while Rendle pointed to an innovation pipeline intended to “create years and years of value” for consumers, especially as household penetration for core brands remains robust.

Key Insights from Management’s Remarks

Management attributed the quarter’s results to ERP implementation challenges, evolving consumer value-seeking behaviors, and a more competitive promotional environment.

• ERP system transition impact: The rollout of the new ERP system in the U.S. led to temporary disruptions in supply chain and order fulfillment, resulting in short-term market share losses, particularly in August. Management stated these issues are being resolved, with fill rates largely returning to normal by the end of the quarter.
• Evolving consumer behavior: Clorox observed continued value-seeking and cautious spending among consumers, leading to increased channel shifting and a higher sensitivity to price and promotion across categories. CEO Linda Rendle noted that promotional activity increased in segments such as trash bags and cat litter, but overall category promotional spending remained in line with expectations.
• Innovation and product launches: The company launched new scent platforms in Glad, expanded Brita’s lineup with smaller, affordable pitchers and filters, and introduced new Burt’s Bees products. Management signaled that innovation efforts would span all major brands, with further launches planned for the back half of the year.
• Portfolio optimization: Clorox divested its Argentina business and exited the vitamins, minerals, and supplements category, reflecting a disciplined focus on strengthening core brands and responding to volatility in less strategic categories.
• Margin and cost management: While input cost inflation was slightly more favorable than initially projected, incremental expenses related to the ERP transition and increased trade spending pressured margins. However, management expects robust gross margin expansion in the second half as efficiencies from the ERP system and targeted spending take hold.

Drivers of Future Performance

Clorox’s guidance for the next few quarters is shaped by category stabilization, a strong innovation pipeline, and ongoing efforts to manage promotional pressures and costs.

• Category growth and market share: Management expects category growth rates to remain flat to slightly positive, with Clorox’s share recovery dependent on successful innovation launches and tailored price pack architecture. The company is closely monitoring private label competition in categories like Brita and bleach, adjusting offerings to maintain consumer relevance.
• Margin recovery and investment: Cost inflation is now expected to be less severe than previously estimated, but tariff headwinds and increased trade and advertising spending will continue to impact margins. Clorox anticipates gross margin expansion in the back half as ERP efficiencies are realized and demand creation investments support higher-value innovation.
• Promotional and competitive dynamics: The environment remains competitive, particularly in trash bags and cat litter, where elevated promotions persist. Clorox is balancing short-term share losses in these areas with a long-term focus on category value creation through innovation and selective investment, aiming to avoid destructive price competition.

Catalysts in Upcoming Quarters

Looking ahead, our analysts will monitor (1) the pace of market share recovery as new product innovations roll out, (2) signs of gross margin expansion from ERP-enabled efficiencies and disciplined marketing spend, and (3) stabilization in core categories such as trash bags and cat litter, where promotional pressures remain elevated. Execution on brand reinvestment and private label defense will also be key indicators of strategic progress.

Clorox currently trades at $112.90, up from $109.01 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free for active Edge members).

High Quality Stocks for All Market Conditions

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.